Novartis, through its CDMO division Novartis Contract Manufacturing, is a multinational biologics and advanced therapy CDMO with cGMP-compliant facilities across Europe, the United States, and Asia. The company provides end-to-end development and manufacturing services for biologics, nucleic acids, plasmid DNA, RNA therapeutics, viral vectors, and cell and gene therapies. Services include mammalian and microbial cell culture, cell bank manufacturing, LNP formulation, peptide synthesis, viral vector production, and aseptic fill/finish, supporting projects from clinical development through commercial production at scale.